Correlation Between Walker Dunlop and BioLine RX

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and BioLine RX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and BioLine RX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and BioLine RX, you can compare the effects of market volatilities on Walker Dunlop and BioLine RX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of BioLine RX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and BioLine RX.

Diversification Opportunities for Walker Dunlop and BioLine RX

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Walker and BioLine is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and BioLine RX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLine RX and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with BioLine RX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLine RX has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and BioLine RX go up and down completely randomly.

Pair Corralation between Walker Dunlop and BioLine RX

Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 0.17 times more return on investment than BioLine RX. However, Walker Dunlop is 5.72 times less risky than BioLine RX. It trades about 0.0 of its potential returns per unit of risk. BioLine RX is currently generating about -0.19 per unit of risk. If you would invest  11,120  in Walker Dunlop on August 29, 2024 and sell it today you would lose (38.00) from holding Walker Dunlop or give up 0.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy82.61%
ValuesDaily Returns

Walker Dunlop  vs.  BioLine RX

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Walker Dunlop are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Walker Dunlop is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
BioLine RX 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLine RX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Walker Dunlop and BioLine RX Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and BioLine RX

The main advantage of trading using opposite Walker Dunlop and BioLine RX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, BioLine RX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLine RX will offset losses from the drop in BioLine RX's long position.
The idea behind Walker Dunlop and BioLine RX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments